-
Article
Acute cardiovascular effects of intravenous cyclosporine
The acute effects of intravenous (i.v.) cyclosporine A (CsA) on blood pressure and other haemodynamic parameters were examined in 8 patients with end-stage renal disease on haemodialysis (HD). The study was pe...
-
Chapter and Conference Paper
In Vivo Effects of Recombinant Human Erythropoietin on Circulating CD34+ Cells of Uremic Patients
Impaired renal production of erythropoietin (EPO) is the main cause of the blunted marrow response to the anemia in end-stage renal disease (ESRD) [1]. Recombinant human EPO (rHuEPO) is being widely used to co...
-
Chapter and Conference Paper
Long-term beneficial effects of azathioprine addition to ongoing cyclosporine-prednisone protocol in renal transplantation
Delayed addition of azathioprine (Aza) to an ongoing cyclosporine-prednisone protocol was started 11.3 ± 9.9 months after renal transplantation in 31 patients. Group I (n = 10) had chronic renal function deterior...
-
Chapter and Conference Paper
Influence of cyclosporin A (CyA) on renal handling of urate
Hyperuricaemia is a frequent side-effect of cyclosporin A (CyA) therapy in renal transplant patients [1,5–7,11], and gout arthritis is the cause of considerable morbidity among these patients [5,7,8,10,11]. Ho...
-
Chapter
Is Serum Urea a Good Index for Predicting Morbidity in Hemodialysis (HD)?
Blood urea nitrogen (BUN) has been considered a useful guide in the prescription and assessment of diet and dialysis therapy 1 since a direct relationship has been shown between the former and hospitalization rat...
